The scientists are not sure how AS01 might lower the risk of dementia, though the effect is likely to involve the immune system in the brain, which has been shown in recent research to play an ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how ...

Scientists behind a study suggesting GSK's RSV vaccine may be protective against dementia have said the adjuvant used in it may be responsible.

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

Hugo Francisco de Souza is a Ph.D. scholar cum scientific writer based in Bangalore, Karnataka, India. His academic passions lie in biogeography, evolutionary biology, and herpetology. He is ...

The vaccine already in use in Mozambique is the second recommended by the WHO, following RTS,S/AS01 in 2021, based on the advice of the Strategic Advisory Group of Experts on Immunisation (SAGE) and ...

Incredible value: Save up to $700 or 53% off during Amazon Prime Day, the best time to upgrade your tech. Something for ...

In a recent doctoral thesis from the Norwegian University of Science and Technology (NTNU), more than 500 caregivers describe ...

--Eli Lilly and Company today announced detailed results from ACHIEVE-1, a Phase 3 trial evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and ...

How the Shingles Vaccine Guards Against Dementia: New Clues New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting against dementia.